(0.59%) 5 158.02 points
(0.35%) 38 812 points
(0.57%) 16 249 points
(0.74%) $78.69
(4.20%) $2.23
(1.27%) $2 337.90
(3.20%) $27.54
(0.43%) $969.45
(-0.17%) $0.927
(-0.56%) $10.81
(-0.29%) $0.795
(0.02%) $91.47
-0.25% € 91.07
Live Chart Being Loaded With Signals
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 196 405 |
Średni wolumen | 1.39M |
Kapitalizacja rynkowa | 114.09B |
EPS | €1.780 ( 2024-04-30 ) |
Następna data zysków | ( €1.580 ) 2024-07-24 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | 25.37 |
ATR14 | €0.0410 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2014-07-10 | Sanofi | Buy | 17 286 | Common Stock |
2014-07-10 | Sanofi | Buy | 18 057 | Common Stock |
2014-07-10 | Sanofi | Buy | 20 638 | Common Stock |
2014-07-10 | Sanofi | Buy | 15 815 | Common Stock |
2014-07-10 | Sanofi | Buy | 53 994 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 9 transactions |
Buy: 175 000 | Sell: 0 |
Wolumen Korelacja
Sanofi SA Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sanofi SA Korelacja - Waluta/Towar
Sanofi SA Finanse
Annual | 2023 |
Przychody: | €43.07B |
Zysk brutto: | €26.50B (61.52 %) |
EPS: | €4.31 |
FY | 2023 |
Przychody: | €43.07B |
Zysk brutto: | €26.50B (61.52 %) |
EPS: | €4.31 |
FY | 2022 |
Przychody: | €45.39B |
Zysk brutto: | €31.70B (69.83 %) |
EPS: | €6.69 |
FY | 2021 |
Przychody: | €39.18B |
Zysk brutto: | €26.92B (68.72 %) |
EPS: | €4.96 |
Financial Reports:
No articles found.
Sanofi SA
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej